Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
Junwei Yang, … , Kari Nejak, Youhua Liu
Junwei Yang, … , Kari Nejak, Youhua Liu
Published November 15, 2002
Citation Information: J Clin Invest. 2002;110(10):1525-1538. https://doi.org/10.1172/JCI16219.
View: Text | PDF
Article Nephrology

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy

  • Text
  • PDF
Abstract

Research Article

Authors

Junwei Yang, Ryan W. Shultz, Wendy M. Mars, Rodney E. Wegner, Yingjian Li, Chunsun Dai, Kari Nejak, Youhua Liu

×

Figure 8

Options: View larger image (or click on image) Download as PowerPoint
Deficiency of tPA preserves the functional integrity of TBM in the obstr...
Deficiency of tPA preserves the functional integrity of TBM in the obstructed kidneys. TBM functional integrity was determined by bacterial translocation across the reconstituted TBM. (a) Schematic depiction of experimental procedures. Matrigels (15 μm thick) analogous to native TBM matrix were formed on Transwell filters and incubated with whole-tissue lysates of the obstructed kidneys collected 7 days after UUO from tPA+/+ and tPA–/– mice. The integrity of the Matrigels was assessed by bacterial translocation through the gels. Representative plates show the colonies formed from the bacteria that passed through the Matrigels after incubation with tissue extracts from either tPA+/+ (b) or tPA–/– (c) mice. (d) Graphic presentation of the numbers of bacteria translocated through the Matrigels (n = 5). *P < 0.01 vs. tPA+/+ mice. (e) Zymographic analysis shows the specificity of MMP-9 inhibitor. Tissue lysates from the obstructed kidneys of either tPA+/+ or tPA–/– mice were separated on a polyacrylamide gel containing 1 mg/ml gelatin. A potent MMP-9 inhibitor (MMP inhibitor II) was included in the developing buffer at a concentration of 10 nM. The locations of bands corresponding to MMP-9 and MMP-2 are indicated. Numbered lanes indicate two animals per group. (f) Graphic presentation of the numbers of bacteria translocated through Matrigels preincubated with kidney lysates in the presence of 10 nM MMP-9 inhibitor. No statistically significant difference was found between tPA+/+ and tPA–/– groups.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts